FDA And EMA Evaluate Claims As Nitrosamine Worries Turn To Zantac

 
• By Bowman Cox
  
collage of the periodic table and test tubes, pipette
Will regulators confirm that ranitidine risks were missed for decades?
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance